Yihe Daida to United States
This is a "connection" page, showing publications Yihe Daida has written about United States.
Connection Strength
0.551
-
Mental and physical health status among chronic hepatitis B patients. Qual Life Res. 2020 Jun; 29(6):1567-1577.
Score: 0.086
-
COVID-19 vaccination in pregnancy and postpartum and human milk feeding non-initiation and discontinuation. Am J Epidemiol. 2026 08 05; 195(8):2121-2130.
Score: 0.034
-
Impact of Disease-Specific Treatment and Non-Selective Beta Blockers on Risk of PVT in Cirrhotic Patients With HCV or PBC. Liver Int. 2026 05; 46(5):e70628.
Score: 0.033
-
Language and racial disparities in COVID-19 vaccination during pregnancy and lactation. Vaccine. 2026 Jun 11; 83:128638.
Score: 0.033
-
Antiviral treatment and statin use and risk of decompensated cirrhosis in patients with hepatitis C: a time-dependent analysis of a retrospective cohort study. BMJ Open Gastroenterol. 2026 Mar 27; 13(1).
Score: 0.033
-
Comparison of Lactation Information from Electronic Health Records with Survey Data Across Five US Health Systems. Epidemiology. 2026 Mar 01; 37(2):198-206.
Score: 0.033
-
Assessment of adherence to guidelines for biochemical monitoring and ursodeoxycholic acid treatment response in a retrospective cohort of US patients with primary biliary cholangitis. BMJ Open Gastroenterol. 2025 Oct 22; 12(1).
Score: 0.032
-
Adolescents Who Do Not Endorse Risk via the Patient Health Questionnaire Before Self-Harm or Suicide. JAMA Psychiatry. 2024 Jul 01; 81(7):717-726.
Score: 0.029
-
Clozapine Use Among People With Psychotic Disorders Who Experience Specific Indications for Clozapine. J Clin Psychiatry. 2024 Apr 29; 85(2).
Score: 0.029
-
Age at lung cancer diagnosis in females versus males who never smoke by race and ethnicity. Br J Cancer. 2024 May; 130(8):1286-1294.
Score: 0.028
-
Prevalence of hepatitis B virus (HBV) and latent tuberculosis co-infection and risk of drug-induced liver injury across two large HBV cohorts in the United States. J Viral Hepat. 2023 06; 30(6):512-519.
Score: 0.027
-
Low Uptake of Direct-acting Antiviral Therapy Among Hepatitis C Patients With Advanced Liver Disease and Access to Care, 2014-2017. J Clin Gastroenterol. 2021 01; 55(1):77-83.
Score: 0.023
-
Psychosocial Obstacles to Hepatitis C Treatment Initiation Among Patients in Care: A Hitch in the Cascade of Cure. Hepatol Commun. 2021 03; 5(3):400-411.
Score: 0.023
-
Mortality Among Patients With Chronic Hepatitis B Infection: The Chronic Hepatitis Cohort Study (CHeCS). Clin Infect Dis. 2019 03 05; 68(6):956-963.
Score: 0.020
-
Sustained virological response does not improve long-term glycaemic control in patients with type 2 diabetes and chronic hepatitis C. Liver Int. 2019 06; 39(6):1027-1032.
Score: 0.020
-
Impact of sustained virologic response on risk of type 2 diabetes among hepatitis C patients in the United States. J Viral Hepat. 2018 08; 25(8):952-958.
Score: 0.019
-
Hepatitis B Virus Infection and Hepatitis C Virus Treatment in a Large Cohort of Hepatitis C-Infected Patients in the United States. Gastroenterology. 2018 02; 154(3):754-758.
Score: 0.019
-
Changing trends in complications of chronic hepatitis C. Liver Int. 2018 02; 38(2):239-247.
Score: 0.018
-
KRAS testing and epidermal growth factor receptor inhibitor treatment for colorectal cancer in community settings. Cancer Epidemiol Biomarkers Prev. 2013 Jan; 22(1):91-101.
Score: 0.013